Insulin therapy remains a cornerstone in the management of diabetes mellitus, a chronic metabolic disorder affecting millions worldwide. As healthcare systems strive to optimize resource allocation, economic evaluations play a crucial role in assessing the cost-effectiveness of various treatment modalities. This systematic review aims to synthesize existing literature on the economic evaluations of insulin therapies, analyzing their cost-effectiveness, affordability and implications for healthcare policy and practice.
HTML PDFShare this article
Pharmacoeconomics: Open Access received 95 citations as per Google Scholar report
